Abnova (Taiwan) Corporation (TPE:4133)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
20.15
-0.35 (-1.71%)
Jul 14, 2026, 1:30 PM CST

Abnova (Taiwan) Revenue

Abnova (Taiwan) had revenue of 87.91M TWD in the quarter ending March 31, 2026, a decrease of -2.86%. This brings the company's revenue in the last twelve months to 348.71M, down -3.34% year-over-year. In the year 2025, Abnova (Taiwan) had annual revenue of 351.30M, down -1.11%.

Revenue (ttm)
348.71M
Revenue Growth
-3.34%
P/S Ratio
3.56
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.24B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025351.30M-3.96M-1.11%
Dec 31, 2024355.26M-26.80M-7.01%
Dec 31, 2023382.05M-29.70M-7.21%
Dec 31, 2022411.76M-39.73M-8.80%
Dec 31, 2021451.49M-4.96M-1.09%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Level Biotechnology718.58M
GenMont Biotech Incorporation390.95M
NeoCore Technology235.54M
Lukas Biomedical179.49M
Enimmune48.19M
TaiRx27.88M
Revenue Rankings